Nathalie Ledee/LinkedIn
Sep 29, 2025, 11:50
Nathalie Ledee Highlights Emerging Insights from ESHRE 2025
Nathalie Ledee, Obstetrician Gynecologist and PhD, CEO at MatriceLab, shared a post on LinkedIn:
“It was a great pleasure to spend a whole day immersed in the exciting world of reproductive immunology at this wonderful, huge ESHRE2025 congress. It became clear that immunosuppressive therapies cannot be prescribed indiscriminately. Precision care requires a diagnosis. Another good news is that the concept that endometrial immune equilibrium may help weak embryos (while not being necessary for top-quality ones) is now emerging. Further studies will reveal more about this crucial issue.”
-
Sep 18, 2026, 20:27Hrishikesh Pai: Rethinking Male Infertility
-
Sep 18, 2026, 20:25Eric Verdin: Wrapping Up the Reproductive Aging Summit at the Center for Healthy Aging in Women
-
Sep 18, 2026, 20:21Investigating Pregnancy Outcomes in Women with Idiopathic POI – RBMO
-
Sep 18, 2026, 20:18Sue Ritchie: Why Aren’t We Talking About Male Fertility More?
-
Sep 18, 2026, 20:13Salma Yasin: Every Day of BFS Study Week 2026 Has Been an Exceptional Learning Experience
-
Sep 18, 2026, 20:01Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?
-
Sep 18, 2026, 19:58Bhumika: Can a Woman Become Pregnant Again While Already Pregnant?
-
Sep 18, 2026, 19:5215 More Experts Join the International Fertility Forum Mumbai 2026
-
Sep 18, 2026, 19:50Curious About What Happens Behind the Scenes in the Labs? – Sims IVF